Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …

P Urban, R Mehran, R Colleran, DJ Angiolillo… - Circulation, 2019 - Am Heart Assoc
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …

CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies

AB Reiss, N Miyawaki, J Moon, LJ Kasselman… - Atherosclerosis, 2018 - Elsevier
Mineral bone disease (MBD) is a common complication of chronic kidney disease (CKD)
characterized by disruption of normal mineral homeostasis within the body. One or more of …

Antithrombotic therapy in patients with chronic kidney disease

D Capodanno, DJ Angiolillo - Circulation, 2012 - Am Heart Assoc
Chronic kidney disease (CKD) is a pandemic public health problem, with 500 million people
worldwide estimated to have some form of kidney injury. 1 Survey data suggest that the …

Interpretable machine learning models for predicting in-hospital and 30 days adverse events in acute coronary syndrome patients in Kuwait

MA Alkhamis, M Al Jarallah, S Attur, M Zubaid - Scientific Reports, 2024 - nature.com
The relationships between acute coronary syndromes (ACS) adverse events and the
associated risk factors are typically complicated and nonlinear, which poses significant …

Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the …

AJ Saltzman, GW Stone, BE Claessen, A Narula… - JACC: Cardiovascular …, 2011 - jacc.org
Objectives: This study sought to investigate the impact of chronic kidney disease (CKD) in
patients undergoing percutaneous coronary intervention (PCI) for ST-segment elevation …

Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association

JB Washam, CA Herzog, AL Beitelshees, MG Cohen… - Circulation, 2015 - Am Heart Assoc
As shown in Figure 2, there is a stepwise incremental age-standardized risk for all-cause
mortality, cardiovascular events, and hospitalization associated with diminishing renal …

Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry

U Baber, R Mehran, AJ Kirtane, PA Gurbel… - Circulation …, 2015 - Am Heart Assoc
Background—Chronic kidney disease (CKD) is associated with increased rates of adverse
events after percutaneous coronary intervention. We sought to determine the impact of CKD …

Framing cause-effect relationship of acute coronary syndrome in patients with chronic kidney disease

MI Moisi, SG Bungau, CM Vesa, CC Diaconu, T Behl… - Diagnostics, 2021 - mdpi.com
The main causes of death in patients with chronic kidney disease (CKD) are of
cardiovascular nature. The interaction between traditional cardiovascular risk factors (CVRF) …

Impact of Chronic Kidney Disease on the Processes of Care and Long‐Term Mortality of Non–ST‐Segment–Elevation Myocardial Infarction: A Nationwide Cohort …

N Weight, S Moledina, M Ullah… - Journal of the …, 2024 - ahajournals.org
Background A growing population of patients with chronic kidney disease (CKD) presents
with non–ST‐segment–elevation myocardial infarction, although little is known about their …

[HTML][HTML] Chronic kidney disease in acute coronary syndromes

G Marenzi, A Cabiati, E Assanelli - World journal of nephrology, 2012 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is associated with a high burden of coronary artery disease.
In patients with acute coronary syndromes (ACS), CKD is highly prevalent and associated …